Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, June 18, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tiago Fauth Downgraded (AVTE) to Hold and Decreased Target to $2 on, Jun 18th, 2024
Tiago Fauth of Wells Fargo, Downgraded "Aerovate Therapeutics, Inc." (AVTE) to Hold and Decreased Target from $35 to $2 on, Jun 18th, 2024.
Tiago has made no other calls on AVTE in the last 4 months.
There are 3 other peers that have a rating on AVTE. Out of the 3 peers that are also analyzing AVTE, 2 agree with Tiago's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Eun Yang of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $2 on, Monday, June 17th, 2024
- Julian Harrison of "BTIG" Downgraded from Strong Buy to Hold on, Monday, June 17th, 2024
This is the rating of the analyst that currently disagrees with Tiago
- Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $41 on, Thursday, June 6th, 2024
